Gilles Carmel
- Hematology top 1%
- Multiple Myeloma Research and Treatments 5
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 6
- Ubiquitin and proteasome pathways 6
- Fungal and yeast genetics research 3
- Oncology top 5%
- Physiology top 10%
- Cell Biology top 10%
-
- Enzyme Structure and Function 5
-
- Bacterial Genetics and Biotechnology 4
-
- Bacteriophages and microbial interactions 3
-
- Microbial Natural Products and Biosynthesis 2
- Co-authors
- Jeff KuretLester I. BinderEdward M. MagerBrian E. CathersAntonia Lopez‐GironaEmily RychakHiroshi HandaTakumi Ito
- Cited by
- HematologyMolecular BiologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (3 papers)The EMBO Journal (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Gilles Carmel
21 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Hematology 755
- Molecular Biology 1.9k
- Oncology 504
- Physiology 346
- Cell Biology 196
Countries citing papers authored by Gilles Carmel
This map shows the geographic impact of Gilles Carmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Carmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Carmel more than expected).
Fields of papers citing papers by Gilles Carmel
This network shows the impact of papers produced by Gilles Carmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Carmel. The network helps show where Gilles Carmel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gilles Carmel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 203 | |
| 2 | Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogsbreakdown → | 2014 | 371 |
| 3 | 2013 | 71 | |
| 4 | Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomidebreakdown → | 2012 | 606 |
| 5 | 2011 | 4 | |
| 6 | 2004 | 58 | |
| 7 | 2002 | 22 | |
| 8 | 2001 | 12 | |
| 9 | 1999 | 147 | |
| 10 | 1996 | 361 | |
| 11 | 1996 | 37 | |
| 12 | 1995 | 161 | |
| 13 | 1994 | 58 | |
| 14 | 1994 | 56 | |
| 15 | 1994 | 31 | |
| 16 | 1992 | 5 | |
| 17 | 1991 | 37 | |
| 18 | 1990 | 25 | |
| 19 | 1986 | 98 | |
| 20 | 1985 | 39 |
About Gilles Carmel
Gilles Carmel is a scholar working on Hematology, Molecular Biology and Biotechnology, having authored 21 papers that have together received 2.5k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (6 papers), Multiple Myeloma Research and Treatments (5 papers), Enzyme Structure and Function (5 papers), Bacterial Genetics and Biotechnology (4 papers), Bacteriophages and microbial interactions (3 papers), Fungal and yeast genetics research (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Hematology (755 citations), Molecular Biology (1.9k citations) and Oncology (504 citations). Gilles Carmel has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Jeff Kuret, Lester I. Binder, Edward M. Mager, Brian E. Cathers, Antonia Lopez‐Girona, Emily Rychak, Hiroshi Handa, Takumi Ito, Xiaodong Cheng and Peter Schäfer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.